Mr. Bergstrom’s recent experience includes transactions in the following industries:

Software and Information Technology

• Intuit Inc., a provider of business and financial management solutions for small businesses, consumers, and accounting professionals, in numerous transactions, including its:
  • US$12 billion acquisition of Mailchimp
  • US$7.1 billion acquisition of Credit Karma
  • US$340 million acquisition of TSheets, Inc.
  • US$1.025 billion sale of Digital Insight, Intuit’s Financial Services division, to Thoma Bravo
  • US$423 million acquisition of Demandforce, Inc. and its subsequent sale to Internet Brands
  • US$360 million acquisition of Check
• Neudesic, a leading cloud services consultancy, in its sale to IBM
• Astound Commerce, a global digital commerce specialist, in its sale of a majority interest to RLH Equity Partners
• PriceSpider, a leading brand commerce company revolutionizing retail data technology, in its sale of a majority interest to Frontier Capital
• Pipedrive, a sales CRM Platform, in its sale of a majority interest to Vista Equity Partners
• Bread Financial (formerly Alliance Data Systems), in various transactions, including the sale of its Epsilon business unit to Publicis Group

Internet & Digital Media

• Indeed.com, the American worldwide employment website for job listings, in various acquisitions
• Khosla Ventures Acquisition Co. II in its deSPAC merger with NextDoor, the online neighborhood network
• Chess.com, one of the world's largest online chess platforms, in its sale of a substantial growth investment to General Atlantic
• OpenTable, Inc., a web-based service provider of restaurant reservations, in its US$2.6 billion sale to the Priceline Group
• Twitch Interactive, Inc., an operator of a live video platform for online gaming, in its US$970 million sale to a multi-national technology company
• eBay Inc. in its US$945 million acquisition of Bill Me Later, Inc.
• Seamless North America, LLC, a leading provider of mobile and online portals that provide restaurant information and services, in its merger with GrubHub

Semiconductors

• Avago Technologies Limited, a provider of analog semiconductors, custom chips, radio-frequency and microwave components, in its:
  • US$37 billion acquisition of Broadcom Corp.
  • US$6.6 billion acquisition of LSI Corporation
  • US$400 million acquisition of CyOptics
  • US$240 million sale of its Printer ASICs business to Marvell Technology Group Ltd.
  • US$70 million sale of its CMOS image sensor business to Micron Technology
• IXYS Corporation, a provider of power semiconductors, radio frequency power semiconductors, and digital and analog integrated circuits, in various transactions, including its sale to Littelfuse

Life Sciences

• Afferent Pharmaceuticals, a clinical-stage biopharmaceutical company, in its acquisition by Merck
• MAP Pharmaceuticals, Inc., a drug and pharmaceutical company, in its US$958 million sale to Allergan, Inc.
• Labrys Biologics, Inc., a biotechnology firm developing antibody treatments for chronic migraines, in its US$825 million sale to Teva Pharmaceutical Industries
• FerroKin BioSciences, Inc., a biotechnology company, in its US$325 million sale to Shire plc
• KAI Pharmaceuticals, a privately held pharmaceuticals company, in its US$315 million sale to Amgen
• Complete Genomics, Inc., a developer of DNA sequencing products and services, in its US$117 million sale to BGI Shenzhen
• Pionyr Immunotherapeutics, a clinical stage company developing cancer therapies, in its negotiation with Gilead Sciences of a structured financing and option to purchase Pionyr
• Transcept Pharmaceuticals, a specialty pharmaceutical company focused on the development and commercialization of proprietary products in the neuroscience field, in its reverse merger with Paratek Pharmaceuticals

Medical Devices

• Sorin S.p.A., a global medical device company, in its US$2.7 billion merger with Cyberonics
• Ulthera, a medical device company focused on the development and commercialization of various technologies for aesthetic and medical applications, in its:
  • US$600 million sale to Merz
  • Acquisition of Cabochon Aesthetics
• Sadra Medical, Inc., a company pioneering new therapies to minimize the invasiveness of treating aortic valve disease, in its US$450 million sale to Boston Scientific Corporation
• Maya Medical, a nascent hypertension product company, in its US$230 million sale to Covidien
• Zonare Medical Systems, a US based ultrasound company, in its US$105 million sale to Mindray Medical International Limited
• FlowCardia, Inc., a California medical device company, in its sale to C. R. Bard, Inc.
• Hotspur Technologies, Inc., a developer of catheter-based technologies, in its sale to Teleflex Medical, Inc.
• Harpoon Medical, a medical device company focused on the treatment of heart disease, in its negotiation with Edwards Lifesciences of a structured financing and option to purchase Harpoon
• Kalila Medical, a medical device company developing steerable catheter technologies for atrial fibrillation and other electrophysiology procedures, in its sale to Abbott Laboratories

Private Equity

Mr. Bergstrom’s private equity experience includes:

• ArchiMed SAS and its various portfolio companies in numerous transactions, including ArchiMed’s pending acquisition of Natus Medical
• The Veritas Capital Vantage Fund and its various portfolio companies in numerous acquisitions
• Behrman Capital in various transactions, including most recently, its sales of Pelican Products, New ILC Dover and Data Device Corporation
• SRS Acquiom in its sale of a majority interest to Lovell Minnick Partners
• Canada Pension Plan Investment Board, in its acquisition of a 48% stake in GlobalLogic, Inc. a global leader in digital product development services
• Bridgepoint Advisers, in its acquisition with Summit Partners of Calypso Technology, a provider of financial market software solutions